Clinical Trials Logo

Myofacial Pain clinical trials

View clinical trials related to Myofacial Pain.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05673655 Enrolling by invitation - Myofacial Pain Clinical Trials

Intraoral Injection of Trigger Points by Botox

Start date: December 25, 2022
Phase: Phase 2
Study type: Interventional

Patients with orofacial pain lasting at least 3 months. The patients will be randomly assigned to one of the two groups according to the treatment method: group I (intraoral injection) and group II (transcutaneous injection) where each patient injected Botox at each trigger point according to the treatment group by the same operator. Patients will be examined by a blinded investigator at pre- and post-injections at the following intervals: during diagnosis, 1 week, 4, and 6 weeks post-injection. The patients will be assessed using a pain score measured on a 10-point visual analog scale (VAS). The secondary outcome assessed will be measuring the quality of life in an Oral Health Impact Profile questionnaire (OHIP-14).